Testosterone/Finasteride Pellet (Partell Specialty Pharmacy) – Sterility Concern (2018)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Testosterone/Finasteride 60 mg/5 mg pellet Amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
Brand
Partell Specialty Pharmacy
Lot Codes / Batch Numbers
Lot#: 20171012@63, BUD 04/10/2018, 20171127@103, BUD 05/26/2018, 20180115@69, BUD 07/14/2018.
Products Sold
Lot#: 20171012@63, BUD 04/10/2018, 20171127@103, BUD 05/26/2018, 20180115@69, BUD 07/14/2018.
Partell Specialty Pharmacy is recalling Testosterone/Finasteride 60 mg/5 mg pellet Amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. due to Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
NV
Page updated: Jan 7, 2026